Method Specially Adapted For Identifying A Library Member Patents (Class 506/2)
-
Publication number: 20140256563Abstract: Provided is a high throughput methylation detection method, particularly a combined sequence capture and bisulfite sequencing method. The method accurately and effectively analyzes the methylation status of the target area in several samples simultaneously, lowers the difficulty of probe design, enhances operation and application feasibility, and enables high throughput methylation detection of high accuracy on interested target sequences and areas in a complete genome. The method is targeted and conserves energy and time.Type: ApplicationFiled: May 22, 2012Publication date: September 11, 2014Applicant: BGI TECH SOLUTIONS CO., LTD.Inventors: Huijuan Luo, Guanyu Ji, Hui Jiang, Mingzhi Wu, Jihua Sun, Renhua Wu, Junwen Wang, Fei Gao
-
Publication number: 20140256565Abstract: The present invention relates to methods for reducing the ambiguity in human leukocyte antigen (HLA) allele identification. In particular, the methods comprise using target specific oligonucleotide (TSO) techniques to determine a first set of possible HLA alleles. The methods further comprise using sequence-based typing (SBT) to obtain a second set of possible HLA alleles. The two sets of the possible HLA alleles are then combined to determine at least one common allele identified in the both the TSO and SBT assays, thus reducing the ambiguity associated with current HLA typing procedures.Type: ApplicationFiled: February 20, 2014Publication date: September 11, 2014Applicant: LIFE TECHNOLOGIES CORPORATIONInventors: DAVID DINAUER, INTA KALVE, MARY PARLOW
-
Publication number: 20140249036Abstract: The present disclosure provides methods of characterizing one or more microorganisms and kits for characterizing at least one microorganism. Exemplary methods include preparing an amplicon library, sequencing a characteristic gene sequence to obtain a gene sequence, and characterizing the one or more microorganisms based on the gene sequence using a computer-based genomic analysis of the gene sequence. Exemplary kits include at least one forward primer including an adapter sequence and a priming sequence, for a target sequence, and at least one reverse primer.Type: ApplicationFiled: March 4, 2014Publication date: September 4, 2014Inventors: Stephen E. Fry, Jeremy Ellis
-
Publication number: 20140249037Abstract: The present disclosure provides methods of characterizing one or more microorganisms and kits for characterizing at least one microorganism. Exemplary methods include preparing an amplicon library, sequencing a characteristic gene sequence to obtain a gene sequence, and characterizing the one or more microorganisms based on the gene sequence using a computer-based genomic analysis of the gene sequence. Exemplary kits include at least one forward primer including an adapter sequence and a priming sequence, for a target sequence, and at least one reverse primer.Type: ApplicationFiled: March 4, 2014Publication date: September 4, 2014Inventors: Stephen E. Fry, Jeremy Ellis
-
Publication number: 20140249038Abstract: Disclosed are a method of detecting a pre-determined event in a nucleic acid sample and a system thereof. The method of detecting the pre-determined event in the nucleic acid sample comprises the following steps: constructing a sequencing-library for the nucleic acid sample; sequencing the sequencing-library to obtain a sequencing result consisting of a plurality of sequencing data; determining the sequencing data from a pre-determined region; and determining an occurrence of the pre-determined event in the nucleic acid sample based on a composition of the sequencing data from the pre-determined region.Type: ApplicationFiled: December 21, 2011Publication date: September 4, 2014Applicant: BGI Diagnosis Co., LtdInventors: Hui Jiang, Fang Chen, Huijuan Ge, Peipei Li, Xuchao Li, Jian Wang, Jun Wang, Huanming Yang, Xiuqing Zhang
-
Publication number: 20140243210Abstract: An immunoglobulin binding peptide having the general formula, from amino terminus to carboxy terminus, of Z—R1—R2—R3—R4—R5—R6—X, is described, wherein: R1 is H or Y; R2 is a hydrophobic, preferentially aromatic, amino acid (for example W, F, Y, V); R3 is a positively charged or aromatic amino acid (for example R, H, F, W); R4 is a hydrophobic or positively charged amino acid (for example G, Y, R, K, L); R5 is a positively charged or aromatic amino acid (for example W, F, R, H, Y); R6 a random amino acid but preferably hydrophobic or negatively charged (for example V, W, L, D, H); X is present or absent and when present is a linking group; and Z is present or absent and when present is a capping group bonded to the N terminus of R1; and wherein the amino acids of said peptide are in D form, L form, or a combination thereof.Type: ApplicationFiled: May 2, 2012Publication date: August 28, 2014Inventors: Ruben Carbonell, Haiou Yang, Patrick Gurgel
-
Publication number: 20140243213Abstract: The present invention relates to methods for determining the sequence bias of a sequencing technique. Furthermore, the invention relates to methods to reduce or enhance sequence bias during sequencing of nucleic acids via techniques involving adaptor ligations. Specifically the method relates to use of a degenerate RNA sequence to analyse sequence bias when generating small RNA libraries, and to the use of modified adaptors for cloning of small RNAs with degenerate or specific sequences to reduce or enhance sequencing bias, as well as various nucleic acid molecules relating thereto or derived therefrom.Type: ApplicationFiled: July 27, 2012Publication date: August 28, 2014Applicant: University of East AngliaInventors: Karim Sorefan, Tamas Dalmay, Vincent Moulton, Helio Ernesto Coronel M. Pais
-
Publication number: 20140243211Abstract: Biomarkers and methods for screening expression levels of the biomarkers for predicting and tracking suicidality, as well as for monitoring response to a treatment for suicidal risk and for determining suicidal risk as a side-effect of an antidepressant are disclosed.Type: ApplicationFiled: February 28, 2014Publication date: August 28, 2014Inventor: Alexander B. Niculescu
-
Publication number: 20140243212Abstract: Methods are provided for diagnosing pregnancy-associated disorders, determining allelic ratios, determining maternal or fetal contributions to circulating transcripts, and/or identifying maternal or fetal markers using a sample from a pregnant female subject. Also provided is use of a gene for diagnosing a pregnancy-associated disorder in a pregnant female subject.Type: ApplicationFiled: February 28, 2014Publication date: August 28, 2014Applicant: The Chinese University of Hong KongInventors: Yuk-Ming Dennis Lo, Rossa Wai Kwun Chiu, Kwan Chee Chan, Peiyong Jiang, Bo Yin Tsui
-
Publication number: 20140243215Abstract: The invention provides a method of diagnosing a disease or a predisposition to contract a disease by assaying for mutations of uromodulin (UMOD) within a test subject or patient. The presence of a mutation in the UMOD supports a diagnosis of a disease or a predisposition to contract a disease within the patient.Type: ApplicationFiled: May 5, 2014Publication date: August 28, 2014Applicants: University of Pittsburgh - Of the Commonwealth System of Higher Education, Wake Forest UniversityInventors: Thomas C. Hart, Patricia Suzanne Hart, Michael Gorry, Anthony J. Bleyer
-
Publication number: 20140243214Abstract: In an FET configuration having a channel with a small thickness, transistor characteristics vary for different FETs in the same array, and therefore when the same gate voltage is applied, the sensitivities of DNA detection may be insufficient. To this end, the change in the channel current when DNA passes through the nanopore is detected while applying an optimum gate voltage for each nanopore FET to attain a predetermined channel current value to a plurality of nanopore FETs disposed on the same substrate, and four types of bases constituting DNA are distinguished.Type: ApplicationFiled: February 26, 2013Publication date: August 28, 2014Applicant: Hitachi, Ltd.Inventors: Takanobu Haga, Itaru Yanagi, Naoshi Itabashi, Yoshimitsu Yanagawa, Takeshi Ohura, Takashi Anazawa
-
Publication number: 20140243216Abstract: The present invention pertains to a method for isolating nucleic acids by size from a sample comprising nucleic acids of different sizes using an anion exchange matrix, wherein nucleic acids of a preselected size or a preselected size range are isolated by varying the pH value during elution and/or binding.Type: ApplicationFiled: September 25, 2012Publication date: August 28, 2014Inventors: Roland Fabis, Nadine Krüger, Jan Petzel
-
Patent number: 8815512Abstract: The invention relates to a method for the high throughput discovery, detection and genotyping of one or more genetic markers in one or more samples, comprising the steps of restriction endonuclease digest of DNA, adaptor-ligation, optional pre-amplification, selective amplification, pooling of the amplified products, sequencing the libraries with sufficient redundancy, clustering followed by identification of the genetic markers within the library and/or between libraries and determination of (co-)dominant genotypes of the genetic markers.Type: GrantFiled: November 1, 2012Date of Patent: August 26, 2014Assignee: KeyGene N.V.Inventors: Michael Josephus Theresia Van Eijk, Anker Preben Sørensen, Marco Geradus Maria Van Schriek
-
Publication number: 20140234289Abstract: Engineered nucleases (e.g., zinc finger nucleases (ZFNs), transcriptional activator-like effector nucleases (TALENs), and others) are promising tools for genome manipulation and determining off-target cleavage sites of these enzymes is of great interest. We developed an in vitro selection method that interrogates 1011 DNA sequences for their ability to be cleaved by active, dimeric nulceases, e.g., ZFNs and TALENs. The method revealed hundreds of thousands of DNA sequences, some present in the human genome, that can be cleaved in vitro by two ZFNs, CCR5-224 and VF2468, which target the endogenous human CCR5 and VEGF-A genes, respectively. Analysis of the identified sites in cultured human cells revealed CCR5-224-induced mutagenesis at nine off-target loci. Similarly, we observed 31 off-target sites cleaved by VF2468 in cultured human cells.Type: ApplicationFiled: July 22, 2012Publication date: August 21, 2014Applicant: President and Fellows of Harvard CollegeInventors: David R. Liu, John Paul Guilinger, Vikram Pattanayak
-
Publication number: 20140235459Abstract: The present invention relates to screening methods for rust resistance or tolerance, in particular, Asian soybean rust (ASR—Phakopsora pachyrhizi). In addition, the present invention relates to the use of molecular markers for the Glycine genus, in particular, for the Glycine max species. The present invention further relates to a method for identifying loci with quantitative and/or qualitative traits associated with rust resistance or tolerance in plants by means of molecular markers. Said markers can be used for assisted screening in improvement programs directed to selecting disease-resistant or -tolerant plants. The present invention also relates to gene pyramiding related to rust resistance. The markers of the present invention are also useful for the positional cloning of rust-resistant or—tolerant genes. Also disclosed are a method for obtaining disease-resistant or—tolerant cultivars, a process for obtaining a plant population and a method for controlling diseases in a plant population.Type: ApplicationFiled: April 25, 2014Publication date: August 21, 2014Applicant: TMG - TROPICAL MELHORAMENTO E GENETICA LTDA.Inventors: Arlindo Harada, Eberson Sanches Calvo, Romeu Afonso de Souza Kiihl, Alexandre Garcia
-
Publication number: 20140235456Abstract: The disclosure provides methods and systems for assessing microsatellites, for identifying informative microsatellite loci, and for using microsatellite data. Microsatellite information has numerous uses including, for example, to characterize disease risk, to predict responsiveness to therapy, and to non-invasively diagnose subjects.Type: ApplicationFiled: December 17, 2013Publication date: August 21, 2014Applicant: VIRGINIA TECH INTELLECTUAL PROPERTIES, INC.Inventors: Harold R. Garner, JR., Lauren J. McIver, Hongseok Tae
-
Publication number: 20140235457Abstract: The invention relate to systems and methods for sequencing polynucleotides, as well as detecting reactions and binding events involving other biological molecules. The systems and methods may employ chamber-free devices and nanosensors to detect or characterize such reactions in high-throughput. Because the system in many embodiments is reusable, the system can be subject to more sophisticated and improved engineering, as compared to single use devices.Type: ApplicationFiled: May 29, 2012Publication date: August 21, 2014Applicant: GENAPSYS, INC.Inventors: Hesaam Esfandyarpour, Kosar Baghbani Parazi, Mark F. Oldham, Eric S. Nordman, Richard T. Reel, Susanne Baumhueter, Cheryl Heiner, Frank Lee
-
Publication number: 20140235453Abstract: The invention relates to global transcription machinery engineering to produce altered cells having improved phenotypes.Type: ApplicationFiled: October 15, 2013Publication date: August 21, 2014Applicant: MASSACHUSETTS INSTITUTE OF TECHNOLOGYInventors: Hal S. Alper, Gregory Stephanopoulos
-
Publication number: 20140235461Abstract: The invention provides methods of determining a consensus sequence from multiple raw sequencing reads of a nucleic acid target. The nucleic acid target includes an anchor segment of known sequence and an adjacent segment of unknown sequence. The anchor segment provides a means to assess the quality of a raw target sequencing read. Raw target sequencing reads meeting or exceeding a threshold are assigned to an accepted class. The consensus sequence of the adjacent segment can be determined from raw target sequencing reads in the accepted class. Successive polling steps determine successive consensus nucleobases in a nascent sequence of the adjacent segment. Raw target sequencing reads can be removed or reintroduced from the accepted class depending on their correspondence to the most recently determined consensus nucleobase and/or the nascent sequence.Type: ApplicationFiled: September 26, 2012Publication date: August 21, 2014Inventors: Tongjia Yin, Steve Brentano, Jennifer Bungo, Xianqun Wang, Michael Hadjisavas
-
Publication number: 20140235460Abstract: The present disclosure provides an improvement to quantitative Nuclease Protection Assay (qNPA) and quantitative Nuclease Protection Sequencing (qNPS) methods. The disclosed methods use nuclease protection probes (NPPs) that include 5?-end and/or 3-end flanking sequences, which provide a universal hybridization and/or amplification sequence. The disclosed methods can be used to sequence or detect target nucleic acid molecules, such as those present in fixed or insoluble samples.Type: ApplicationFiled: May 1, 2014Publication date: August 21, 2014Applicant: HTG Molecular Diagnostics, Inc.Inventors: Debrah Thompson, Bruce E. Seligmann, Debra A. Gordon
-
Publication number: 20140235458Abstract: The present invention provides a microarray useful as a tool in the diagnosis and/or prognosis of certain types of cancers, particularly urogenital cancers. The microarray can include a plurality of genomic regions represented thereon, the genomic regions corresponding to regions wherein alterations, such as copy number aberrations, at such locations correlate to specific, identifiable cancers, particularly prostate, renal, or bladder tumors. The invention further provides methods of diagnosing certain types of cancers, particularly urogenital cancers, more particularly renal cortical cancers. The methods can comprise analyzing genetic material from a human individual to determine the presence or presence of certain aberrations and using a decision tree to classify the subtype of renal cortical neoplasm present in the sample.Type: ApplicationFiled: February 14, 2014Publication date: August 21, 2014Applicant: Cancer Genetics, Inc.Inventors: Jane C. Houldsworth, Raju S.K. Chaganti
-
Publication number: 20140235452Abstract: Methods and apparatus relating to FET arrays including large FET arrays for monitoring chemical and/or biological reactions such as nucleic acid sequencing-by-synthesis reactions. Some methods provided herein relate to improving signal (and also signal to noise ratio) from released hydrogen ions during nucleic acid sequencing reactions.Type: ApplicationFiled: September 15, 2010Publication date: August 21, 2014Applicant: LIFE TECHNOLOGIES CORPORATIONInventors: Jonathan Rothberg, Todd Rearick
-
Publication number: 20140235455Abstract: A method of detecting hepatocellular carcinoma includes the steps of: detecting a methylation level of a CpG site of HOXA9 gene in a biological sample taken from a suspected subject; and comparing the methylation level to a reference methylation level of a CpG site of HOXA9 gene in another biological sample taken from a normal subject not suffering from hepatocellular carcinoma, wherein when the methylation level is higher than the reference methylation level, the suspected subject is likely to suffer from hepatocellular carcinoma, and wherein each of the biological samples is selected from the group consisting of a blood sample, a serum sample, and a plasma sample.Type: ApplicationFiled: December 13, 2013Publication date: August 21, 2014Applicants: ACADEMIA SINICA, TAIPEI MEDICAL UNIVERSITYInventors: Ching-Yu LIN, Jung-Chun LIN, Che-Chang CHANG, Yung-Kai HUANG, Guan Shuh BING, Hsiu-Wen HUANG, Ya-Wen LIN, Hung-Chung LAI, Yu-Lueng SHIH, Chung-Bao HSIEH, Chih-Chi KUO, Pei-Yu LIN, Ming-Song HSIEH, Chien-Jen CHEN
-
Publication number: 20140235454Abstract: There is a need or improved methods for determining the diagnosis and prognosis of patients with conditions, including autoimmune disease and cancer, especially lymphoid neoplasms, such as lymphomas and leukemias. Provided herein are methods for using DNA sequencing to identify personalized, or patient-specific biomarkers in patients with lymphoid neoplasms, autoimmune disease and other conditions. Identified biomarkers can be used to determine and/or monitor the disease state for a subject with an associated lymphoid disorder or autoimmune disease or other condition. In particular, the invention provides a sensitive method for monitoring lymphoid neoplasms that undergo clonal evolutions without the need to development alternative assays for the evolved or mutated clones serving as patient-specific biomarkers.Type: ApplicationFiled: November 8, 2013Publication date: August 21, 2014Applicant: SEQUENTA INC.Inventors: Malek Faham, Thomas Willis
-
Publication number: 20140228226Abstract: Disclosed is a method for determining the chromosome aneuploidy of a single cell and a system for determining the chromosome aneuploidy of a single cell. Among them, the method for determining the chromosome aneuploidy of a single cell according to the embodiments of the present invention comprises: the whole genome of the single cell is sequenced to obtain a first sequencing result; the total number of sequencing data from the first sequencing result is counted, obtaining a value L; the number of sequencing data of a first chromosome from the first sequencing result is counted, obtaining a value M; a first parameter is determined based on the value L and the value M; and it is determined whether or not the single cell has aneuploidy in respect of the first chromosome based on the difference between the first parameter and a predetermined control parameter.Type: ApplicationFiled: September 21, 2011Publication date: August 14, 2014Applicant: BGI HEALTH SERVICE CO., LTD.Inventors: Xuyang Yin, Chunlei Zhang, Yong Qiu, Shengpei Chen, Hui Jiang, Jun Wang, Jian Wang
-
Publication number: 20140228223Abstract: The present invention is related to genomic nucleotide sequencing. In particular, the invention describes a paired end sequencing method that improves the yield of long-distance genomic read pairs by constructing long-insert clone libraries (i.e., for example, a fosIll library or a fosCN library) and converting the long-insert clone library using inverse polymerase chain reaction amplification or shearing and recircularization of shortened fragments into a library of co-ligated clone-insert ends. The resultant jumping libraries are compatible with massively parallel sequencing techniques. The compositions and methods disclosed herein contemplate sequencing complex genomes as well as detecting chromosomal structural rearrangements.Type: ApplicationFiled: May 10, 2011Publication date: August 14, 2014Inventors: Andreas Gnirke, Robert Nicol, Louise Williams, Maura T. Costello, Scott Steelman
-
Publication number: 20140228225Abstract: An optical system configured to detect optical signals during imaging sessions. The optical system includes an objective lens that has a collecting end that is positioned proximate to a sample and configured to receive optical signals therefrom. The optical system also includes a removable path compensator that is configured to be located at an imaging position between the collecting end of the objective lens and the sample. The path compensator adjusts an optical path of the light emissions when in the imaging position. Also, the optical system includes a transfer device that is configured to move the path compensator. The transfer device locates the path compensator at the imaging position for a first imaging session and removes the path compensator from the imaging position for a second imaging session.Type: ApplicationFiled: April 28, 2014Publication date: August 14, 2014Applicant: ILLUMINA, INC.Inventors: ALEXANDER TRIENER, ERIK ALLEGOREN, WENYI FENG, DALE BUERMANN, ERIK OLSON, JAMES OSMUS
-
Publication number: 20140228423Abstract: In embodiments of the present invention, there are methods and compositions related to diagnosis and treatment of serous ovarian cancer. In specific embodiments, the invention encompasses methods related to miR-34c in diagnosis and treatment methods for serous ovarian cancer. In specific embodiments, the invention encompasses treatment methods for pancreatic cancer and other responsive cancers.Type: ApplicationFiled: June 1, 2012Publication date: August 14, 2014Applicant: BAYLOR COLLEGE OF MEDICINEInventors: Martin M. Matzuk, Jaeyeon Kim, Zhifeng Yu
-
Publication number: 20140227372Abstract: The present invention relates, in part, to methods for determining a prognosis of early stage lung cancer in an individual using one or more biomarkers.Type: ApplicationFiled: May 24, 2012Publication date: August 14, 2014Applicant: NOVARTIS AGInventors: Edoardo Missiaglia, Simona Rossi, Pratyaksha Wirapati, Werner Kroll
-
Publication number: 20140228224Abstract: The present disclosure relates to the identification of a QTL associated with high ethanol tolerance in Saccharomyces spp. More specifically, it relates to specific alleles of MKT1 and APJ1 possibly combined with a specific allele of SWS2 that are important in obtaining a high ethanol tolerance in Saccharomyces spp. It relates further to the use of such alleles in the construction of high ethanol tolerant strains, and the use of these alleles in screening for ethanol tolerance.Type: ApplicationFiled: June 20, 2012Publication date: August 14, 2014Inventors: Johan Thevelein, Maria Remedios Foulquié Moreno, Annelies Goovaerts, Steve Swinnen
-
Publication number: 20140221219Abstract: Oligodendrogliomas are the second most common malignant brain tumor in adults. These tumors often contain a chromosomal abnormality involving a pericentromeric fusion of chromosomes 1 and 19, resulting in losses of the entire short arm of the former and the long arm of the latter. To identify the molecular genetic basis for this alteration, we performed exomic sequencing of seven anaplastic oligodendrogliomas with chromosome 1p and 19q losses. Among other changes, we found that that CIC (homolog of the Drosophila gene capicua) on chromosome 19q was somatically mutated in six of the seven cases and that FUBP1 (far upstream element (FUSE) binding protein) on chromosome 1p was somatically mutated in two of the seven cases. Examination of 27 additional oligodendrogliomas revealed 12 and 3 more tumors with mutations of CIC and FUBP1, respectively, 58% of which were predicted to result in truncations of the encoded proteins.Type: ApplicationFiled: July 18, 2012Publication date: August 7, 2014Applicants: DUKE UNIVERSITY, THE JOHNS HOPKINS UNIVERSITYInventors: Bert Vogelstein, Kenneth W. Kinzler, Chetan Bettegowda, Nishant Agrawal, Nickolas Papadopoulos, Darell Bigner, Hai Yan, Roger Mclendon
-
Publication number: 20140221218Abstract: Methods for single-molecule preparation and analysis are disclosed herein. The methods can, for example, be used for isolating and analyzing DNA from various biological samples.Type: ApplicationFiled: February 3, 2014Publication date: August 7, 2014Applicant: Bionano Genomics, Inc.Inventors: Han Cao, Ming Xiao, Alex Hastie, Michael G. Saghbini, Henry B. Sadowski
-
Publication number: 20140221220Abstract: A method of measuring immunocompetence is described. This method provides a means for assessing the effects of diseases or conditions that compromise the immune system and of therapies aimed to reconstitute it. This method is based on quantifying T-cell diversity by calculating the number of diverse T-cell receptor (TCR) beta chain variable regions from blood cells.Type: ApplicationFiled: April 14, 2014Publication date: August 7, 2014Applicant: Fred Hutchinson Cancer Research CenterInventors: Harlan Saul Robins, Edus H. Warren, III, Christopher Scott Carlson
-
Publication number: 20140221217Abstract: The invention relates to a method for the detection of a target nucleotide sequence in a sample based on an oligonucleotide ligation assay wherein probes are used that contain (a combination of) sequence-based identifiers that can identify the sample and the target sequence (i.e. locus and/or allele combination) wherein after the ligation step, the ligated probes, or after amplification, the amplified ligated probes, are restricted using restriction enzymes to cut of part of the probes and continue with those parts (identifiers and target sequence) that contain the relevant information in the sequencing step.Type: ApplicationFiled: July 9, 2012Publication date: August 7, 2014Applicant: Keygene N.V.Inventors: Michael Josephus Theresia Van Eijk, Rene Cornelis Josephus Hogers
-
Publication number: 20140213464Abstract: An apparatus and system are provided for simultaneously analyzing a plurality of analytes anchored to microparticles. Microparticles each having a uniform population of a single kind of analyte attached are disposed as a substantially immobilized planar array inside of a flow chamber where steps of an analytical process are carried out by delivering a sequence of processing reagents to the microparticles by a fluidic system under microprocessor control. In response to such process steps, an optical signal is generated at the surface of each microparticle which is characteristic of the interaction between the analyte carried by the microparticle and the delivered processing reagent. The plurality of analytes are simultaneously analyzed by collecting and recording images of the optical signals generated by all the microparticles in the planar array.Type: ApplicationFiled: April 4, 2014Publication date: July 31, 2014Applicant: ILLUMINA, INC.Inventors: John Bridgham, Kevin Corcoran, George Golda, Michael C. Pallas, Sydney Brenner
-
Publication number: 20140213462Abstract: The invention relates to a method for the high throughput identification of single nucleotide polymorphisms by performing a complexity reduction on two or more samples to yield two or more libraries, sequencing at least part of the libraries, aligning the identified sequences and determining any putative single nucleotide polymorphisms, confirming any putative single nucleotide polymorphism, generating detection probes for the confirmed single nucleotide polymorphisms, subjection a test sample to the same complexity reduction to provide a test library and screen the test library for the presence or absence of the single nucleotide polymorphisms using the detection probe.Type: ApplicationFiled: January 28, 2014Publication date: July 31, 2014Applicant: Keygene N.V.Inventors: Michael Josephus Theresia VAN EIJK, Henricus Johannes Adam Van Der Poel
-
Publication number: 20140213460Abstract: Methods relating to obtaining libraries of YY1-binding long non-coding RNAs, libraries obtained thereby, and methods of use thereof.Type: ApplicationFiled: July 3, 2012Publication date: July 31, 2014Applicant: THE GENERAL HOSPITAL CORPORATIONInventors: Jeannie T. Lee, Yesu Jeon
-
Publication number: 20140213461Abstract: The present invention is directed to compositions and methods for nucleic acid identification and detection. Compositions and methods of the present invention include extracting and fragmenting target nucleic acids from a sample, using the fragmented target nucleic acids to produce target nucleic acid templates and subjecting those target nucleic acid templates to amplification methods to form nucleic acid nanoballs. The invention also includes methods of detecting and identifying sequences using various sequencing applications, including sequencing by ligation methods.Type: ApplicationFiled: August 12, 2013Publication date: July 31, 2014Applicant: Complete Genomics, Inc.Inventors: Radoje Drmanac, Matthew J. Callow
-
Publication number: 20140213463Abstract: A method of measuring immunocompetence is described. This method provides a means for assessing the effects of diseases or conditions that compromise the immune system and of therapies aimed to reconstitute it. This method is based on quantifying T-cell diversity by calculating the number of diverse T-cell receptor (TCR) beta chain variable regions from blood cells.Type: ApplicationFiled: April 2, 2014Publication date: July 31, 2014Applicant: FRED HUTCHINSON CANCER RESEARCH CENTERInventors: Harlan S. Robins, Edus H. Warren, III, Christopher Scott Carlson
-
Publication number: 20140206543Abstract: A method for determining genes in breast cancer that are stable in copy number, expression and sequence in tumors from nearly all patients. Certain stable genes are targets of standard chemotherapy. The effectiveness of therapies that act upon these targets depends on maintaining the stability and integrity of these genes in tumors. Mutations in these targets result in poor response to therapies that target these gene products. In the instant invention, ordinarily stable gene targets are characterized as either normal or mutant for the purpose of determining whether to include or exclude particular drugs as potential treatments.Type: ApplicationFiled: January 18, 2013Publication date: July 24, 2014Inventors: Peter Keith Rogan, Joan Helen Knoll
-
Publication number: 20140206547Abstract: Methods are provided to determine the entire genomic region of a particular HLA locus including both intron and exons. The resultant consensus sequences provides linkage information between different exons, and produces the unique sequence from each of the two genes from the individual sample being typed. The sequence information in intron regions along with the exon sequences provides an accurate HLA haplotype.Type: ApplicationFiled: January 22, 2014Publication date: July 24, 2014Inventors: Chunlin Wang, Michael N. Mindrinos, Mark M. Davis, Ronald W. Davis, Sujatha Krishnakumar
-
Publication number: 20140206549Abstract: A method of measuring immunocompetence is described. This method provides a means for assessing the effects of diseases or conditions that compromise the immune system and of therapies aimed to reconstitute it. This method is based on quantifying T-cell diversity by calculating the number of diverse T-cell receptor (TCR) beta chain variable regions from blood cells.Type: ApplicationFiled: February 18, 2014Publication date: July 24, 2014Applicant: Fred Hutchinson Cancer Research CenterInventors: Harlan Saul Robins, Edus H. Warren, III, Christopher Scott Carlson
-
Publication number: 20140206544Abstract: In one aspect, the invention is directed to a method of characterizing a mechanism of action of a combination of agents. The method comprises contacting a plurality of populations of cells with a combination of agents to be assessed, wherein each population of cells have one gene of interest targeted by a small hairpin RNA (shRNA) and wherein the gene of interest regulates cell death and a plurality of genes that regulate cell death are targeted in the plurality of populations of cells. A responsiveness of each population of cells to the combination of agents is determined, thereby obtaining an shRNA signature of the combination of agents so as to identify one or more genes that mediate a response to the combination of agents, thereby characterizing the mechanism of action of the combination of agents.Type: ApplicationFiled: December 16, 2011Publication date: July 24, 2014Inventors: Justin Pritchard, Douglas A. Lauffenburger, Michael Hemann
-
Publication number: 20140206551Abstract: The present invention relates to a high throughput method for the identification and detection of molecular markers wherein restriction fragments are generated and suitable adaptors comprising (sample-specific) identifiers are ligated. The adapter-ligated restriction fragments may be selectively amplified with adaptor compatible primers carrying selective nucleotides at their 3? end. The amplified adapter-ligated restriction fragments are, at least partly, sequenced using high throughput sequencing methods and the sequence parts of the restriction fragments together with the sample-specific identifiers serve as molecular markers.Type: ApplicationFiled: March 19, 2014Publication date: July 24, 2014Applicant: Keygene N.V.Inventors: Michael Josephus Theresia VAN EIJK, Taco Peter Jesse
-
Publication number: 20140206545Abstract: The present invention relates to gene sets useful in assessing prognosis and/or predicting the response of cancer, e.g. colorectal cancer to chemotherapy. In addition, the invention relates to a clinically validated cancer test, e.g. colorectal test, for assessment of prognosis and/or prediction of patient response to chemotherapy, using expression analysis. The present invention accommodates the use of archived paraffin embedded biopsy material for assay of all markers in the relevant gene sets and therefore is compatible with the most widely available type of biopsy material.Type: ApplicationFiled: December 18, 2013Publication date: July 24, 2014Applicants: NSABP FOUNDATION, INC., GENOMIC HEALTH, INC.Inventors: Joffre B. BAKER, Wayne COWENS, Kim M. CLARK-LANGONE, James HACKETT, Drew WATSON, Soonmyung PAIK
-
Publication number: 20140206548Abstract: A method of measuring immunocompetence is described. This method provides a means for assessing the effects of diseases or conditions that compromise the immune system and of therapies aimed to reconstitute it. This method is based on quantifying T-cell diversity by calculating the number of diverse T-cell receptor (TCR) beta chain variable regions from blood cells.Type: ApplicationFiled: February 18, 2014Publication date: July 24, 2014Applicant: Fred Hutchinson Cancer Research CenterInventors: Harlan Saul Robins, Edus H. Warren, III, Christopher Scott Carlson
-
Publication number: 20140206546Abstract: Methods of obtaining a single cell expression profile from a target mammalian cell are provided. Aspects of the methods include contacting a cellular sample which includes the target mammalian cell with a packaged viral barcoded trans-splicing library including a plurality of barcoded trans-splicing constructs under transduction conditions, where a barcoded trans-splicing construct includes a trans-splicing element linked to a barcode element. The methods further include generating expression data from the resultant transduced target mammalian cell to obtain the single cell expression data from the target mammalian cell. Also provided are compositions, e.g., libraries and components thereof, which find use in practicing the methods.Type: ApplicationFiled: January 13, 2014Publication date: July 24, 2014Inventor: ALEX CHENCHIK
-
Publication number: 20140205607Abstract: Antibody VRC01 represents a human immunoglobulin that neutralizes—˜90% of diverse HIV-1 isolates. To understand how such broadly neutralizing HIV-1 antibodies develop and recognize the viral envelope, we used X-ray crystallography and 454 pyrosequencing to characterize additional antibodies from HIV-1-infected individuals. Crystal structures revealed a convergent mode of binding of different antibodies to the same CD4-binding-site epitope. Antibody recognition was achieved through the evolution of complementary contact domains that were generated in diverse ways. Phylogenetic analysis of expressed heavy and light chains determined by deep sequencing revealed a common pathway of antibody heavy chain maturation confined to IGHV1-2*02 lineage that could pair with different light chains.Type: ApplicationFiled: March 23, 2012Publication date: July 24, 2014Applicants: DUKE UNIVERSITY, and Human ServicesInventors: John R. Mascola, Gary Nabel, Barton F. Haynes, Xueling Wu, Thomas B. Kepler, Peter Kwong
-
Publication number: 20140206550Abstract: The application relates to methods, and systems for nucleotide sequencing comprising producing polymerase reactions that comprise both catalytic and non-catalytic divalent metal ions. Polymerase/template/primer complexes are immobilized on a substrate. The complexes are exposed to a solution comprising a non-catalytic metal and nucleotides labeled with a detectable label on a portion of the nucleotide that is released upon incorporation. The cognate nucleotide is sequestered in the active site of the polymerase, unable to proceed to incorporation. After observing the sequestered cognate nucleotide, the complex is exposed to a catalytic metal, resulting in the incorporation of the bound cognate nucleotide and consequent release of the label resulting in a single-base extended primer.Type: ApplicationFiled: February 20, 2014Publication date: July 24, 2014Applicant: Pacific Biosciences of California, Inc.Inventors: Keith Bjornson, Harold Lee, Jonas Korlach
-
Publication number: 20140206552Abstract: The present disclosure provides methods for determining the ploidy status of an embryo at a chromosome from a sample of DNA from an embryo. The ploidy state is determined by sequencing the DNA from one or more cells biopsied from the embryo, and analyzing the relative amounts of each allele at a plurality of polymorphic loci on the chromosome. In an embodiment, the ploidy state is determined by comparing the observed allele ratios to the expected allele ratios for different ploidy states. In an embodiment, the DNA is selectively amplified at a plurality of polymorphic loci by targeted sequencing. In an embodiment, the mixed sample of DNA may be preferentially enriched at a plurality of polymorphic loci in a way that minimizes the allelic bias.Type: ApplicationFiled: March 25, 2014Publication date: July 24, 2014Applicant: Natera, Inc.Inventors: Matthew Rabinowitz, Matthew Micah Hill, Bernhard Zimmerman, Johan Baner, Allison Ryan, George Gemelos